InvestorsHub Logo

snayeman

04/16/23 9:49 AM

#397413 RE: Snowy_Owl #397412

Yet all the articles and positive testing have led to virtually nothing in terms of value to us shareholders! Why is that is the big question ?????

TheHound

04/16/23 10:53 AM

#397415 RE: Snowy_Owl #397412

To your point…. DeGrado’s most recent blunder. The publication that broke the bank.

https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.27616

CONFLICT OF INTERESTS:
William F. DeGrado is a member of the scientific advisory board of Innovation Pharmaceuticals, a company that is conducting clinical trials on brilacidin.

I regularly remind myself that those who peer review articles put their names and reputations on the line.

Lemoncat

04/17/23 10:18 PM

#397451 RE: Snowy_Owl #397412

Peer reviews aren't meaningless noise.



They aren't meaningless noise at all.

The signal is crystal clear. Every time a peer review article comes out in place of a deal our stock price descends decidedly within six months.